Cargando…

Cognitive impairment six months after ischaemic stroke: a profile from the ASPIRE-S study

BACKGROUND: Cognitive impairment commonly occurs in the acute phase post-stroke, but may persist with over half of all stroke survivors experiencing some form of long-term cognitive deficit. Recent evidence suggests that optimising secondary prevention adherence is a critical factor in preventing re...

Descripción completa

Detalles Bibliográficos
Autores principales: Mellon, Lisa, Brewer, Linda, Hall, Patricia, Horgan, Frances, Williams, David, Hickey, Anne
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2015
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4359388/
https://www.ncbi.nlm.nih.gov/pubmed/25879880
http://dx.doi.org/10.1186/s12883-015-0288-2
_version_ 1782361395898089472
author Mellon, Lisa
Brewer, Linda
Hall, Patricia
Horgan, Frances
Williams, David
Hickey, Anne
author_facet Mellon, Lisa
Brewer, Linda
Hall, Patricia
Horgan, Frances
Williams, David
Hickey, Anne
author_sort Mellon, Lisa
collection PubMed
description BACKGROUND: Cognitive impairment commonly occurs in the acute phase post-stroke, but may persist with over half of all stroke survivors experiencing some form of long-term cognitive deficit. Recent evidence suggests that optimising secondary prevention adherence is a critical factor in preventing recurrent stroke and the incidence of stroke-related cognitive impairment and dementia. The aim of this study was to profile cognitive impairment of stroke survivors at six months, and to identify factors associated with cognitive impairment post-stroke, focusing on indicators of adequate secondary prevention and psychological function. METHODS: Participants were assessed at six months following an ischaemic stroke as part of the Action on Secondary Prevention Interventions and Rehabilitation in Stroke study (ASPIRE-S), which examined the secondary preventive and rehabilitative profile of patients in the community post-stroke. Cognitive impairment was measured using the Montreal Cognitive Assessment (MoCA). RESULTS: Two-hundred and fifty-six stroke patients were assessed at six months. Over half of the sample (56.6%) were found to have cognitive impairment, with significant associations between cognitive impairment and female sex (odds ratio (OR) = 1.6, 95% CI 1.01-2.57) and history of cerebrovascular disease (OR = 2.22, 95% CI 1.38-3.59). Treatment with antihypertensive medications (OR = .65, 95% CI .44-.96) and prescription of anticoagulant therapy (OR = .41, 95% CI .26-.68) were associated with reduced likelihood of cognitive impairment, however increasing number of total prescribed medications was moderately associated with poorer cognitive impairment (OR = 1.12, 95% CI 1.04-1.19). CONCLUSIONS: Findings reveal levels of cognitive impairment at 6 months post-stroke that are concerning. Encouragingly, aspects of secondary prevention were identified that may be protective in reducing the incidence of cognitive impairment post-stroke. Neuropsychological rehabilitation post-stroke is also required as part of stroke rehabilitation models to meet the burden of post-stroke cognitive impairment.
format Online
Article
Text
id pubmed-4359388
institution National Center for Biotechnology Information
language English
publishDate 2015
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-43593882015-03-15 Cognitive impairment six months after ischaemic stroke: a profile from the ASPIRE-S study Mellon, Lisa Brewer, Linda Hall, Patricia Horgan, Frances Williams, David Hickey, Anne BMC Neurol Research Article BACKGROUND: Cognitive impairment commonly occurs in the acute phase post-stroke, but may persist with over half of all stroke survivors experiencing some form of long-term cognitive deficit. Recent evidence suggests that optimising secondary prevention adherence is a critical factor in preventing recurrent stroke and the incidence of stroke-related cognitive impairment and dementia. The aim of this study was to profile cognitive impairment of stroke survivors at six months, and to identify factors associated with cognitive impairment post-stroke, focusing on indicators of adequate secondary prevention and psychological function. METHODS: Participants were assessed at six months following an ischaemic stroke as part of the Action on Secondary Prevention Interventions and Rehabilitation in Stroke study (ASPIRE-S), which examined the secondary preventive and rehabilitative profile of patients in the community post-stroke. Cognitive impairment was measured using the Montreal Cognitive Assessment (MoCA). RESULTS: Two-hundred and fifty-six stroke patients were assessed at six months. Over half of the sample (56.6%) were found to have cognitive impairment, with significant associations between cognitive impairment and female sex (odds ratio (OR) = 1.6, 95% CI 1.01-2.57) and history of cerebrovascular disease (OR = 2.22, 95% CI 1.38-3.59). Treatment with antihypertensive medications (OR = .65, 95% CI .44-.96) and prescription of anticoagulant therapy (OR = .41, 95% CI .26-.68) were associated with reduced likelihood of cognitive impairment, however increasing number of total prescribed medications was moderately associated with poorer cognitive impairment (OR = 1.12, 95% CI 1.04-1.19). CONCLUSIONS: Findings reveal levels of cognitive impairment at 6 months post-stroke that are concerning. Encouragingly, aspects of secondary prevention were identified that may be protective in reducing the incidence of cognitive impairment post-stroke. Neuropsychological rehabilitation post-stroke is also required as part of stroke rehabilitation models to meet the burden of post-stroke cognitive impairment. BioMed Central 2015-03-12 /pmc/articles/PMC4359388/ /pubmed/25879880 http://dx.doi.org/10.1186/s12883-015-0288-2 Text en © Mellon et al.; licensee BioMed Central. 2015 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research Article
Mellon, Lisa
Brewer, Linda
Hall, Patricia
Horgan, Frances
Williams, David
Hickey, Anne
Cognitive impairment six months after ischaemic stroke: a profile from the ASPIRE-S study
title Cognitive impairment six months after ischaemic stroke: a profile from the ASPIRE-S study
title_full Cognitive impairment six months after ischaemic stroke: a profile from the ASPIRE-S study
title_fullStr Cognitive impairment six months after ischaemic stroke: a profile from the ASPIRE-S study
title_full_unstemmed Cognitive impairment six months after ischaemic stroke: a profile from the ASPIRE-S study
title_short Cognitive impairment six months after ischaemic stroke: a profile from the ASPIRE-S study
title_sort cognitive impairment six months after ischaemic stroke: a profile from the aspire-s study
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4359388/
https://www.ncbi.nlm.nih.gov/pubmed/25879880
http://dx.doi.org/10.1186/s12883-015-0288-2
work_keys_str_mv AT mellonlisa cognitiveimpairmentsixmonthsafterischaemicstrokeaprofilefromtheaspiresstudy
AT brewerlinda cognitiveimpairmentsixmonthsafterischaemicstrokeaprofilefromtheaspiresstudy
AT hallpatricia cognitiveimpairmentsixmonthsafterischaemicstrokeaprofilefromtheaspiresstudy
AT horganfrances cognitiveimpairmentsixmonthsafterischaemicstrokeaprofilefromtheaspiresstudy
AT williamsdavid cognitiveimpairmentsixmonthsafterischaemicstrokeaprofilefromtheaspiresstudy
AT hickeyanne cognitiveimpairmentsixmonthsafterischaemicstrokeaprofilefromtheaspiresstudy
AT cognitiveimpairmentsixmonthsafterischaemicstrokeaprofilefromtheaspiresstudy